{"title":"机器人增强混合消融治疗不适当窦性心动过速:世界首创方法。","authors":"Zain Khalpey, Ujjawal Kumar, Alyssa Abraham, Yoaav Krauthammer","doi":"10.1093/icvts/ivae184","DOIUrl":null,"url":null,"abstract":"<p><p>We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to VATS approaches. Ablations normalized the heart rate from 120 to 70bpm. One month later, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing IST management.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Robotic-enhanced hybrid ablation for inappropriate sinus tachycardia: a world-first approach.\",\"authors\":\"Zain Khalpey, Ujjawal Kumar, Alyssa Abraham, Yoaav Krauthammer\",\"doi\":\"10.1093/icvts/ivae184\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to VATS approaches. Ablations normalized the heart rate from 120 to 70bpm. One month later, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing IST management.</p>\",\"PeriodicalId\":73406,\"journal\":{\"name\":\"Interdisciplinary cardiovascular and thoracic surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interdisciplinary cardiovascular and thoracic surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/icvts/ivae184\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"0\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivae184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
我们描述了世界上首次针对不适当窦性心动过速的机器人消融术。一名患有难治性不适当窦性心动过速的26岁女性接受了机器人增强混合消融术,与VATS方法相比,该方法结合了电生理图谱和更佳的可视化和通路。消融术使心率从 120bpm 降至 70bpm。一个月后,她报告症状缓解,生活质量提高。Holter 监测证实没有心动过速发作。这为已经用尽传统治疗方法的患者提供了一种很有前景的替代方法,有可能彻底改变 IST 的治疗方法。
Robotic-enhanced hybrid ablation for inappropriate sinus tachycardia: a world-first approach.
We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to VATS approaches. Ablations normalized the heart rate from 120 to 70bpm. One month later, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing IST management.